Project BioShield Is Topic Of House Hearings July 12 And 14
This article was originally published in The Pink Sheet Daily
Executive Summary
Homeland Security/Emergency Preparedness Subcommittee and Government Reform Committee hearings will focus on countermeasure procurement issues and evaluating the effectiveness of the BioShield Act of 2004.
You may also be interested in...
Emergency Use Of Unapproved Drugs Outlined In FDA Draft Guidance
FDA action on requests for consideration will likely take place within hours or days in an emergency situation, according to the draft document. The agency also encourages submission of candidate products prior to an emergency “at the earliest possible time.”
House Appropriations Subcommittee Plans FDA Hearing July 26
Ag/FDA subcommittee had tabled FDA hearing pending confirmation of a permanent agency commissioner. House cleared FDA 2006 spending in early June.
Second Quarter Earnings Season Heats Up
Amgen, J&J, Sanofi-Aventis, Pfizer, Merck, Roche, Lilly and Schering-Plough are scheduled to report results in upcoming week. Bristol could expand upon plans to sell OTC unit to Novartis the following week.